Cargando…
Chinese patent medicines for the treatment of the common cold: a systematic review of randomized clinical trials
BACKGROUND: Many Chinese patent medicines (CPMs) have been authorized by the Chinese State of Food and Drug Administration for the treatment of the common cold. A number of clinical trials have been conducted and published. However, there is no systematic review or meta-analysis on their efficacy an...
Autores principales: | Chen, Wei, Liu, Bo, Wang, Li-qiong, Ren, Jun, Liu, Jian-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129119/ https://www.ncbi.nlm.nih.gov/pubmed/25074623 http://dx.doi.org/10.1186/1472-6882-14-273 |
Ejemplares similares
-
Chinese Proprietary Herbal Medicine Listed in ‘China National Essential Drug List’ for Common Cold: A Systematic Literature Review
por: Chen, Wei, et al.
Publicado: (2014) -
Chinese patent herbal medicine Huaiqihuang for Henoch-Schonlein purpura nephritis in children: a systematic review of randomized controlled trials
por: Xue, Xue, et al.
Publicado: (2021) -
Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhang, Xiao-Wen, et al.
Publicado: (2022) -
Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
por: Liang, Shi-Bing, et al.
Publicado: (2021) -
Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
por: Liang, Shi-Bing, et al.
Publicado: (2021)